IP-10 has been ascribed a role in BBB disruption in neurodegenerative morbidities as well as in infectious diseases, emphasizing a potential role of barrier impairment in Ureaplasma-driven neuroinflammation (Wang et al. 2018; Ramesh et al. 2013). The gene discussed is CXCL10; the disease is infectious disease.